AFP and hepatocellular carcinoma: Third, although AFP ≥ 100 ng/mL, AFP-L3 ≥ 10%, and DCP ≥ 100 mAU/mL were used in this study based on previous reports, more optimal cut-off values for this prognostic predicting system should be examined for patients with unresectable HCC treated with Atez/Bev.